Technical Analysis for IMUC - Immunocellular Thera

Grade Last Price % Change Price Change
grade C 0.03 0.00% 0.0000
IMUC closed unchanged on Wednesday, July 8, 2020, on 19 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical IMUC trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Older signals for IMUC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
Medicine Health Biotechnology RTT Cancer Treatment Of Cancer Cancers Oncology Immunotherapy Cancer Immunotherapy Ovarian Cancer Glioblastoma Immunotherapies Virotherapy Brain Tumor Glioblastoma Multiforme Northwest Biotherapeutics Solid Tumor Cancers California Institute Of Technology Johns Hopkins University Steam The Johns Hopkins University

Is IMUC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.0501
52 Week Low 0.012
Average Volume 87,324
200-Day Moving Average 0.0324
50-Day Moving Average 0.0261
20-Day Moving Average 0.0259
10-Day Moving Average 0.0276
Average True Range 0.0044
ADX 34.91
+DI 9.5082
-DI 3.4426
Chandelier Exit (Long, 3 ATRs ) 0.0168
Chandelier Exit (Short, 3 ATRs ) 0.0332
Upper Bollinger Band 0.0308
Lower Bollinger Band 0.0210
Percent B (%b) 0.92
BandWidth 37.8378
MACD Line 0.0011
MACD Signal Line 0.0005
MACD Histogram 0.0006
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0372
Resistance 3 (R3) 0.0364 0.0332 0.0360
Resistance 2 (R2) 0.0332 0.0314 0.0336 0.0356
Resistance 1 (R1) 0.0316 0.0302 0.0324 0.0324 0.0352
Pivot Point 0.0284 0.0284 0.0288 0.0288 0.0284
Support 1 (S1) 0.0268 0.0266 0.0276 0.0276 0.0248
Support 2 (S2) 0.0236 0.0254 0.0240 0.0244
Support 3 (S3) 0.0220 0.0236 0.0240
Support 4 (S4) 0.0228